![A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit | SpringerLink A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-015-1717-1/MediaObjects/262_2015_1717_Fig1_HTML.gif)
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit | SpringerLink
![IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer](https://www.mdpi.com/ijms/ijms-24-05954/article_deploy/html/images/ijms-24-05954-g001.png)
IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
![Towards the development of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: In vitro assessment and cytocompatibility studies - ScienceDirect Towards the development of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: In vitro assessment and cytocompatibility studies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224719316491-fx1.jpg)
Towards the development of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: In vitro assessment and cytocompatibility studies - ScienceDirect
![Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places](https://www.researchgate.net/profile/Panagiotis-Stefanidis/publication/259451194/figure/fig4/AS:668854829191184@1536478826824/Research-area-and-position-of-Meteorological-stations-of-Meg-Panagia-and-Taxiarhis_Q320.jpg)
Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places
![Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places](https://www.researchgate.net/profile/Fotis-Maris/publication/257198280/figure/fig4/AS:650788179283974@1532171401743/Land-use-in-the-research-area-Abb-6-Landnutzung-im-Untersuchungsgebiet_Q320.jpg)
Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places
![Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review | Acta Pharmacologica Sinica Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review | Acta Pharmacologica Sinica](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Faps.2017.212/MediaObjects/41401_2018_95_Fig1_HTML.jpg)
Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review | Acta Pharmacologica Sinica
![IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer](https://pub.mdpi-res.com/ijms/ijms-24-05954/article_deploy/html/images/ijms-24-05954-g004.png?1679447056)
IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
![Ioannis KALAVROUZIOTIS | Professor | Hellenic Open University, Pátra | School of Science and Technology | Research profile Ioannis KALAVROUZIOTIS | Professor | Hellenic Open University, Pátra | School of Science and Technology | Research profile](https://i1.rgstatic.net/ii/profile.image/840973345120257-1577515078229_Q512/Ioannis-Kalavrouziotis.jpg)